var eventsData = [{"Ticker":"CVX","EffectiveDate":"2017-01-27","Type":"EarningsRevenueMiss","Title":"Before market open, CVX reports 2016 Q4's earning $0.22 per share and revenue $31497MM. This misses analyst's estimated EPS $0.66, misses estimated revenue $33850MM.","DailyReturn":"-2.36%","FiveDayReturnAfter":"-3.79%","FiveDayReturnBefore":"0.83%"},{"Ticker":"CVX","EffectiveDate":"2017-01-10","Type":"RatingNeutral","Title":"HSBC downgrades CVX to Hold from Buy.","DailyReturn":"-0.75%","FiveDayReturnAfter":"0.37%","FiveDayReturnBefore":"-1.59%"},{"Ticker":"CVX","EffectiveDate":"2017-01-04","Type":"RatingUpgrade","Title":"Bank of America upgrades CVX to Buy from Neutral.","DailyReturn":"-0.02%","FiveDayReturnAfter":"-2.48%","FiveDayReturnBefore":"-0.48%"},{"Ticker":"CVX","EffectiveDate":"2016-12-15","Type":"RatingUpgrade","Title":"Macquarie upgrades CVX to Outperform. Target Price is $130; previously $90.","DailyReturn":"0.94%","FiveDayReturnAfter":"1.66%","FiveDayReturnBefore":"1.31%"},{"Ticker":"CVX","EffectiveDate":"2016-12-01","Type":"RatingUpgrade","Title":"Independent Research upgrades CVX to Buy from Hold.","DailyReturn":"1.55%","FiveDayReturnAfter":"2.54%","FiveDayReturnBefore":"0.84%"},{"Ticker":"CVX","EffectiveDate":"2016-11-16","Type":"Dividend","Title":"The Firm pays dividend $1.08","DailyReturn":"0.43%","FiveDayReturnAfter":"2.5%","FiveDayReturnBefore":"1.54%"},{"Ticker":"CVX","EffectiveDate":"2016-11-15","Type":"RatingUpgrade","Title":"CLSA upgrades CVX to Buy from Outperform.","DailyReturn":"2.22%","FiveDayReturnAfter":"4.3%","FiveDayReturnBefore":"-0.24%"},{"Ticker":"CVX","EffectiveDate":"2016-11-01","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades CVX to Overweight from Equal-Weight.","DailyReturn":"1.65%","FiveDayReturnAfter":"1.98%","FiveDayReturnBefore":"3.98%"},{"Ticker":"CVX","EffectiveDate":"2016-10-31","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CVX to Buy from Neutral.","DailyReturn":"0.89%","FiveDayReturnAfter":"0.92%","FiveDayReturnBefore":"2.45%"},{"Ticker":"CVX","EffectiveDate":"2016-10-28","Type":"EarningsRevenueBeat","Title":"Before market open, CVX reports 2016 Q3's earning $0.68 per share and revenue $30140MM. This beats analyst's estimated EPS $0.45, beats estimated revenue $29050MM.","DailyReturn":"3.9%","FiveDayReturnAfter":"5.32%","FiveDayReturnBefore":"-1.93%"},{"Ticker":"CVX","EffectiveDate":"2016-10-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"3.9%","FiveDayReturnAfter":"5.32%","FiveDayReturnBefore":"-1.93%"},{"Ticker":"CVX","EffectiveDate":"2016-10-17","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.27%","FiveDayReturnAfter":"0.21%","FiveDayReturnBefore":"-1.17%"},{"Ticker":"CVX","EffectiveDate":"2016-09-13","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on CVX to Outperform. Target Price is $120.","DailyReturn":"-2.75%","FiveDayReturnAfter":"-4.2%","FiveDayReturnBefore":"1.29%"},{"Ticker":"CVX","EffectiveDate":"2016-08-17","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":"0.65%","FiveDayReturnAfter":"0.12%","FiveDayReturnBefore":"1.27%"},{"Ticker":"CVX","EffectiveDate":"2016-08-09","Type":"RatingUpgrade","Title":"PiperJaffray upgrades CVX to Overweight from Neutral.","DailyReturn":"0.11%","FiveDayReturnAfter":"1.53%","FiveDayReturnBefore":"2.08%"},{"Ticker":"CVX","EffectiveDate":"2016-08-08","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.68%","FiveDayReturnAfter":"1.62%","FiveDayReturnBefore":"-1.94%"},{"Ticker":"CVX","EffectiveDate":"2016-08-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.68%","FiveDayReturnAfter":"1.62%","FiveDayReturnBefore":"-1.94%"},{"Ticker":"CVX","EffectiveDate":"2016-07-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.67%","FiveDayReturnAfter":"-1.38%","FiveDayReturnBefore":"-3.47%"},{"Ticker":"CVX","EffectiveDate":"2016-07-29","Type":"EarningsRevenueBeat","Title":"Before market open, CVX reports 2016 Q2's earning $0.49 per share and revenue $29282MM. This beats analyst's estimated EPS $0.33, beats estimated revenue $28540MM.","DailyReturn":"0.67%","FiveDayReturnAfter":"-1.38%","FiveDayReturnBefore":"-3.47%"},{"Ticker":"CVX","EffectiveDate":"2016-07-11","Type":"RatingNeutral","Title":"Jefferies maintains CVX to Buy. Target Price is $116; previously $114.","DailyReturn":"0.59%","FiveDayReturnAfter":"2.13%","FiveDayReturnBefore":"-0.05%"},{"Ticker":"CVX","EffectiveDate":"2016-05-25","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"1.57%","FiveDayReturnAfter":"0.93%","FiveDayReturnBefore":"-0.55%"},{"Ticker":"CVX","EffectiveDate":"2016-05-17","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":"-0.46%","FiveDayReturnAfter":"-1.83%","FiveDayReturnBefore":"1.91%"},{"Ticker":"CVX","EffectiveDate":"2016-05-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.53%","FiveDayReturnAfter":"0.1%","FiveDayReturnBefore":"-1.1%"},{"Ticker":"CVX","EffectiveDate":"2016-05-16","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.53%","FiveDayReturnAfter":"0.1%","FiveDayReturnBefore":"-1.1%"},{"Ticker":"CVX","EffectiveDate":"2016-04-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.21%","FiveDayReturnAfter":"-0.96%","FiveDayReturnBefore":"0.98%"},{"Ticker":"CVX","EffectiveDate":"2016-04-29","Type":"EarningsMissRevenueBeat","Title":"Before market open, CVX reports 2016 Q1's earning $-0.39 per share and revenue $23553MM. This misses analyst's estimated EPS $-0.1, beats estimated revenue $22210MM.","DailyReturn":"-0.21%","FiveDayReturnAfter":"-0.96%","FiveDayReturnBefore":"0.98%"},{"Ticker":"CVX","EffectiveDate":"2016-04-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.52%","FiveDayReturnAfter":"-0.95%","FiveDayReturnBefore":"1.76%"},{"Ticker":"CVX","EffectiveDate":"2016-04-08","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $97; previously $89.","DailyReturn":"1.62%","FiveDayReturnAfter":"3.3%","FiveDayReturnBefore":"-0.64%"},{"Ticker":"CVX","EffectiveDate":"2016-03-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.07%","FiveDayReturnAfter":"-2.81%","FiveDayReturnBefore":"-1.16%"},{"Ticker":"CVX","EffectiveDate":"2016-03-22","Type":"RatingNeutral","Title":"Raymond James downgrades CVX to Market Perform from Outperform.","DailyReturn":"-0.97%","FiveDayReturnAfter":"-1.16%","FiveDayReturnBefore":"2.28%"},{"Ticker":"CVX","EffectiveDate":"2016-03-18","Type":"RatingNeutral","Title":"Nomura initiates coverage on CVX to Neutral. Target Price is $85.","DailyReturn":"0.82%","FiveDayReturnAfter":"-2.12%","FiveDayReturnBefore":"3.09%"},{"Ticker":"CVX","EffectiveDate":"2016-03-18","Type":"RatingNeutral","Title":"Goldman Sachs maintains CVX to Neutral. Target Price is $96; previously $94.","DailyReturn":"0.82%","FiveDayReturnAfter":"-2.12%","FiveDayReturnBefore":"3.09%"},{"Ticker":"CVX","EffectiveDate":"2016-03-11","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CVX to Neutral from Sell.","DailyReturn":"0.68%","FiveDayReturnAfter":"3.09%","FiveDayReturnBefore":"7.06%"},{"Ticker":"CVX","EffectiveDate":"2016-03-09","Type":"RatingUpgrade","Title":"Wolfe Research upgrades CVX to Outperform from Peer Perform.","DailyReturn":"4.59%","FiveDayReturnAfter":"6.04%","FiveDayReturnBefore":"2.98%"},{"Ticker":"CVX","EffectiveDate":"2016-03-09","Type":"RatingNeutral","Title":"RBC Capital maintains CVX to Sector Perform. Target Price is $90; previously $84.","DailyReturn":"4.59%","FiveDayReturnAfter":"6.04%","FiveDayReturnBefore":"2.98%"},{"Ticker":"CVX","EffectiveDate":"2016-03-09","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Neutral. Target Price is $96; previously $84.","DailyReturn":"4.59%","FiveDayReturnAfter":"6.04%","FiveDayReturnBefore":"2.98%"},{"Ticker":"CVX","EffectiveDate":"2016-02-16","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":"0.53%","FiveDayReturnAfter":"5.15%","FiveDayReturnBefore":"3.03%"},{"Ticker":"CVX","EffectiveDate":"2016-01-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.64%","FiveDayReturnAfter":"-1.32%","FiveDayReturnBefore":"5.83%"},{"Ticker":"CVX","EffectiveDate":"2016-01-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.64%","FiveDayReturnAfter":"-1.32%","FiveDayReturnBefore":"5.83%"},{"Ticker":"CVX","EffectiveDate":"2016-01-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.98%","FiveDayReturnAfter":"-3.48%","FiveDayReturnBefore":"3.15%"},{"Ticker":"CVX","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Baird initiates coverage on CVX to Outperform. Target Price is $108.","DailyReturn":"2.62%","FiveDayReturnAfter":"5.31%","FiveDayReturnBefore":"-3.93%"},{"Ticker":"CVX","EffectiveDate":"2016-01-07","Type":"RatingNeutral","Title":"Deutsche Bank maintains CVX to Buy. Target Price is $103; previously $106.","DailyReturn":"-3.54%","FiveDayReturnAfter":"-5.66%","FiveDayReturnBefore":"-5.84%"},{"Ticker":"CVX","EffectiveDate":"2015-12-16","Type":"RatingUpgrade","Title":"Argus Research upgrades CVX to Buy from Hold.","DailyReturn":"0.73%","FiveDayReturnAfter":"-2.72%","FiveDayReturnBefore":"7.05%"},{"Ticker":"CVX","EffectiveDate":"2015-12-15","Type":"RatingNeutral","Title":"JP Morgan maintains CVX to Overweight. Target Price is $91; previously $94.","DailyReturn":"3.83%","FiveDayReturnAfter":"-0.1%","FiveDayReturnBefore":"2.32%"},{"Ticker":"CVX","EffectiveDate":"2015-12-02","Type":"RatingUpgrade","Title":"Citigroup upgrades CVX to Buy from Neutral. Target Price is $110; previously $95.","DailyReturn":"-2.41%","FiveDayReturnAfter":"-6.75%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CVX","EffectiveDate":"2015-11-17","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.45%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"0.26%"},{"Ticker":"CVX","EffectiveDate":"2015-11-17","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.45%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"0.26%"},{"Ticker":"CVX","EffectiveDate":"2015-11-16","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":"4.38%","FiveDayReturnAfter":"1.58%","FiveDayReturnBefore":"-5.85%"},{"Ticker":"CVX","EffectiveDate":"2015-11-03","Type":"RatingUpgrade","Title":"Evercore ISI Group upgrades CVX to Buy from Hold.","DailyReturn":"3.34%","FiveDayReturnAfter":"-2.81%","FiveDayReturnBefore":"6.74%"},{"Ticker":"CVX","EffectiveDate":"2015-11-02","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Neutral. Target Price is $100; previously $87.","DailyReturn":"4.48%","FiveDayReturnAfter":"3.4%","FiveDayReturnBefore":"-0.39%"},{"Ticker":"CVX","EffectiveDate":"2015-10-30","Type":"EarningsRevenueBeat","Title":"Before market open, CVX reports 2015 Q3's earning $1.09 per share and revenue $34315MM. This beats analyst's estimated EPS $0.78, beats estimated revenue $29880MM.","DailyReturn":"1.1%","FiveDayReturnAfter":"5.05%","FiveDayReturnBefore":"-1.9%"},{"Ticker":"CVX","EffectiveDate":"2015-10-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.1%","FiveDayReturnAfter":"5.05%","FiveDayReturnBefore":"-1.9%"},{"Ticker":"CVX","EffectiveDate":"2015-10-12","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $96; previously $99.","DailyReturn":"-0.92%","FiveDayReturnAfter":"1.9%","FiveDayReturnBefore":"9.38%"},{"Ticker":"CVX","EffectiveDate":"2015-09-30","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"3.44%","FiveDayReturnAfter":"13.17%","FiveDayReturnBefore":"-1.3%"},{"Ticker":"CVX","EffectiveDate":"2015-09-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.44%","FiveDayReturnAfter":"13.17%","FiveDayReturnBefore":"-1.3%"},{"Ticker":"CVX","EffectiveDate":"2015-09-25","Type":"RatingUpgrade","Title":"Wolfe Research upgrades CVX to Peer Perform from Underperform.","DailyReturn":"1.05%","FiveDayReturnAfter":"1.86%","FiveDayReturnBefore":"-3.22%"},{"Ticker":"CVX","EffectiveDate":"2015-09-23","Type":"RatingNeutral","Title":"Macquarie initiates coverage on CVX to Underperform. Target Price is $65.","DailyReturn":"-1.46%","FiveDayReturnAfter":"-1.3%","FiveDayReturnBefore":"0.1%"},{"Ticker":"CVX","EffectiveDate":"2015-09-11","Type":"RatingUpgrade","Title":"JP Morgan upgrades CVX to Overweight from Neutral. Target Price is $86; previously $90.","DailyReturn":"0.17%","FiveDayReturnAfter":"4.83%","FiveDayReturnBefore":"-3.12%"},{"Ticker":"CVX","EffectiveDate":"2015-09-08","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Neutral. Target Price is $87; previously $110.","DailyReturn":"0.22%","FiveDayReturnAfter":"-1.18%","FiveDayReturnBefore":"-4.78%"},{"Ticker":"CVX","EffectiveDate":"2015-08-24","Type":"RatingUpgrade","Title":"Bank of America upgrades CVX to Neutral from Underperform. Target Price is $100; previously $104.","DailyReturn":"-4.8%","FiveDayReturnAfter":"5.98%","FiveDayReturnBefore":"-11.41%"},{"Ticker":"CVX","EffectiveDate":"2015-08-17","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":"-1.99%","FiveDayReturnAfter":"-11.41%","FiveDayReturnBefore":"2.63%"},{"Ticker":"CVX","EffectiveDate":"2015-08-05","Type":"RatingNeutral","Title":"RBC Capital maintains CVX to Sector Perform. Target Price is $101; previously $102.","DailyReturn":"-1.38%","FiveDayReturnAfter":"0.66%","FiveDayReturnBefore":"-8.1%"},{"Ticker":"CVX","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"RBC Capital maintains CVX to Sector Perform. Target Price is $101; previously $102.","DailyReturn":"-3.25%","FiveDayReturnAfter":"-5.49%","FiveDayReturnBefore":"-2.36%"},{"Ticker":"CVX","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $99; previously $110.","DailyReturn":"-3.25%","FiveDayReturnAfter":"-5.49%","FiveDayReturnBefore":"-2.36%"},{"Ticker":"CVX","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"Citigroup maintains CVX to Neutral. Target Price is $95; previously $104.","DailyReturn":"-3.25%","FiveDayReturnAfter":"-5.49%","FiveDayReturnBefore":"-2.36%"},{"Ticker":"CVX","EffectiveDate":"2015-07-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-4.89%","FiveDayReturnAfter":"-8.8%","FiveDayReturnBefore":"0.09%"},{"Ticker":"CVX","EffectiveDate":"2015-07-07","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $110; previously $115.","DailyReturn":"0.52%","FiveDayReturnAfter":"-0.17%","FiveDayReturnBefore":"-3.96%"},{"Ticker":"CVX","EffectiveDate":"2015-06-16","Type":"RatingUpgrade","Title":"Societe Generale upgrades CVX to Buy from Hold.","DailyReturn":"0.75%","FiveDayReturnAfter":"1%","FiveDayReturnBefore":"-1.13%"},{"Ticker":"CVX","EffectiveDate":"2015-06-01","Type":"RatingNeutral","Title":"Deutsche Bank maintains CVX to Buy. Target Price is $125; previously $120.","DailyReturn":"-0.35%","FiveDayReturnAfter":"-1.37%","FiveDayReturnBefore":"-2.38%"},{"Ticker":"CVX","EffectiveDate":"2015-05-28","Type":"RatingNeutral","Title":"JP Morgan maintains CVX to Neutral. Target Price is $114; previously $116.","DailyReturn":"0.12%","FiveDayReturnAfter":"-0.91%","FiveDayReturnBefore":"-1.83%"},{"Ticker":"CVX","EffectiveDate":"2015-05-27","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.17%","FiveDayReturnAfter":"-0.68%","FiveDayReturnBefore":"-3.2%"},{"Ticker":"CVX","EffectiveDate":"2015-05-18","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CVX to Sell from Neutral. Target Price is $99; previously $111.","DailyReturn":"-1.27%","FiveDayReturnAfter":"-2.94%","FiveDayReturnBefore":"0.41%"},{"Ticker":"CVX","EffectiveDate":"2015-05-15","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":"0.6%","FiveDayReturnAfter":"-1.77%","FiveDayReturnBefore":"0.81%"},{"Ticker":"CVX","EffectiveDate":"2015-05-04","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $115; previously $110.","DailyReturn":"-0.66%","FiveDayReturnAfter":"-0.35%","FiveDayReturnBefore":"-0.75%"},{"Ticker":"CVX","EffectiveDate":"2015-05-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.81%","FiveDayReturnAfter":"-3.19%","FiveDayReturnBefore":"0.98%"},{"Ticker":"CVX","EffectiveDate":"2015-03-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.41%","FiveDayReturnAfter":"0.74%","FiveDayReturnBefore":"0.99%"},{"Ticker":"CVX","EffectiveDate":"2015-03-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.41%","FiveDayReturnAfter":"0.74%","FiveDayReturnBefore":"0.99%"},{"Ticker":"CVX","EffectiveDate":"2015-03-09","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on CVX to Neutral. Target Price is $110.","DailyReturn":"0.38%","FiveDayReturnAfter":"-1.88%","FiveDayReturnBefore":"-2.97%"},{"Ticker":"CVX","EffectiveDate":"2015-03-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.69%","FiveDayReturnAfter":"-1.85%","FiveDayReturnBefore":"-1.83%"},{"Ticker":"CVX","EffectiveDate":"2015-03-03","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.69%","FiveDayReturnAfter":"-1.85%","FiveDayReturnBefore":"-1.83%"},{"Ticker":"CVX","EffectiveDate":"2015-02-24","Type":"RatingNeutral","Title":"Oppenheimer downgrades CVX to Perform from Outperform.","DailyReturn":"0.09%","FiveDayReturnAfter":"-1.83%","FiveDayReturnBefore":"-4.46%"},{"Ticker":"CVX","EffectiveDate":"2015-02-12","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":"1.79%","FiveDayReturnAfter":"-0.51%","FiveDayReturnBefore":"1.49%"},{"Ticker":"CVX","EffectiveDate":"2015-02-02","Type":"RatingNeutral","Title":"JP Morgan maintains CVX to Neutral. Target Price is $111; previously $118.","DailyReturn":"3.44%","FiveDayReturnAfter":"6.67%","FiveDayReturnBefore":"-4.12%"},{"Ticker":"CVX","EffectiveDate":"2015-01-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.45%","FiveDayReturnAfter":"5.94%","FiveDayReturnBefore":"-5.58%"},{"Ticker":"CVX","EffectiveDate":"2015-01-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-4.2%","FiveDayReturnAfter":"1.16%","FiveDayReturnBefore":"1.66%"},{"Ticker":"CVX","EffectiveDate":"2015-01-28","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-4.2%","FiveDayReturnAfter":"1.16%","FiveDayReturnBefore":"1.66%"},{"Ticker":"CVX","EffectiveDate":"2015-01-23","Type":"RatingNeutral","Title":"Credit Suisse downgrades CVX to Neutral from Outperform.","DailyReturn":"-1.9%","FiveDayReturnAfter":"-5.58%","FiveDayReturnBefore":"4.71%"},{"Ticker":"CVX","EffectiveDate":"2015-01-21","Type":"RatingNeutral","Title":"Wells Fargo downgrades CVX to Market Perform.","DailyReturn":"1.58%","FiveDayReturnAfter":"1.66%","FiveDayReturnBefore":"0.55%"},{"Ticker":"CVX","EffectiveDate":"2015-01-15","Type":"RatingNeutral","Title":"Jefferies maintains CVX to Buy. Target Price is $125; previously $129.","DailyReturn":"-1.18%","FiveDayReturnAfter":"4.71%","FiveDayReturnBefore":"-3.81%"},{"Ticker":"CVX","EffectiveDate":"2015-01-14","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $115; previously $141.","DailyReturn":"-0.28%","FiveDayReturnAfter":"3.72%","FiveDayReturnBefore":"-3.6%"},{"Ticker":"CVX","EffectiveDate":"2015-01-05","Type":"RatingNeutral","Title":"Citigroup downgrades CVX to Neutral from Buy. Target Price is $115; previously $125.","DailyReturn":"-3.99%","FiveDayReturnAfter":"-3.95%","FiveDayReturnBefore":"-0.78%"},{"Ticker":"CVX","EffectiveDate":"2014-12-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-2%","FiveDayReturnAfter":"-5.08%","FiveDayReturnBefore":"-6.34%"},{"Ticker":"CVX","EffectiveDate":"2014-12-10","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-2%","FiveDayReturnAfter":"-5.08%","FiveDayReturnBefore":"-6.34%"},{"Ticker":"CVX","EffectiveDate":"2014-12-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2%","FiveDayReturnAfter":"-5.08%","FiveDayReturnBefore":"-6.34%"},{"Ticker":"CVX","EffectiveDate":"2014-12-08","Type":"RatingNeutral","Title":"Oppenheimer maintains CVX to Outperform. Target Price is $130; previously $140.","DailyReturn":"-3.67%","FiveDayReturnAfter":"-7.96%","FiveDayReturnBefore":"1.82%"},{"Ticker":"CVX","EffectiveDate":"2014-12-01","Type":"RatingNeutral","Title":"Citigroup maintains CVX to Buy. Target Price is $125; previously $141.","DailyReturn":"2.62%","FiveDayReturnAfter":"1.82%","FiveDayReturnBefore":"-7.46%"},{"Ticker":"CVX","EffectiveDate":"2014-11-24","Type":"RatingNeutral","Title":"Raymond James downgrades CVX to Outperform from Strong Buy. Target Price is $140.","DailyReturn":"-0.83%","FiveDayReturnAfter":"-5.95%","FiveDayReturnBefore":"1.92%"},{"Ticker":"CVX","EffectiveDate":"2014-11-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.24%","FiveDayReturnAfter":"1.57%","FiveDayReturnBefore":"-0.93%"},{"Ticker":"CVX","EffectiveDate":"2014-11-18","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.24%","FiveDayReturnAfter":"1.57%","FiveDayReturnBefore":"-0.93%"},{"Ticker":"CVX","EffectiveDate":"2014-11-14","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":"0.81%","FiveDayReturnAfter":"1.65%","FiveDayReturnBefore":"-1.77%"},{"Ticker":"CVX","EffectiveDate":"2014-11-03","Type":"RatingNeutral","Title":"JP Morgan maintains CVX to Neutral. Target Price is $126; previously $130.","DailyReturn":"-2.64%","FiveDayReturnAfter":"-0.96%","FiveDayReturnBefore":"3.42%"},{"Ticker":"CVX","EffectiveDate":"2014-10-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.34%","FiveDayReturnAfter":"1.12%","FiveDayReturnBefore":"0.86%"},{"Ticker":"CVX","EffectiveDate":"2014-10-21","Type":"RatingNeutral","Title":"Jefferies maintains CVX to Buy. Target Price is $138; previously $140.","DailyReturn":"3.22%","FiveDayReturnAfter":"3.11%","FiveDayReturnBefore":"-0.48%"},{"Ticker":"CVX","EffectiveDate":"2014-09-23","Type":"RatingNeutral","Title":"JP Morgan initiates coverage on CVX to Neutral. Target Price is $133.","DailyReturn":"-0.34%","FiveDayReturnAfter":"-2.4%","FiveDayReturnBefore":"-0.6%"},{"Ticker":"CVX","EffectiveDate":"2014-09-09","Type":"RatingNeutral","Title":"Bank of America downgrades CVX to Underperform from Neutral. Target Price is $133; previously $135.","DailyReturn":"-0.81%","FiveDayReturnAfter":"-1.57%","FiveDayReturnBefore":"-2.53%"},{"Ticker":"CVX","EffectiveDate":"2014-08-15","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":"0.16%","FiveDayReturnAfter":"1.6%","FiveDayReturnBefore":"1.03%"},{"Ticker":"CVX","EffectiveDate":"2014-08-14","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.5%","FiveDayReturnAfter":"0.76%","FiveDayReturnBefore":"1.47%"},{"Ticker":"CVX","EffectiveDate":"2014-08-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.5%","FiveDayReturnAfter":"0.76%","FiveDayReturnBefore":"1.47%"},{"Ticker":"CVX","EffectiveDate":"2014-08-04","Type":"RatingNeutral","Title":"Morgan Stanley downgrades CVX to Equal-Weight from Overweight.","DailyReturn":"0.21%","FiveDayReturnAfter":"-0.03%","FiveDayReturnBefore":"-4.33%"},{"Ticker":"CVX","EffectiveDate":"2014-08-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.03%","FiveDayReturnAfter":"-2.81%","FiveDayReturnBefore":"-4.24%"},{"Ticker":"CVX","EffectiveDate":"2014-07-25","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $141; previously $130.","DailyReturn":"-0.94%","FiveDayReturnAfter":"-4.24%","FiveDayReturnBefore":"3.6%"},{"Ticker":"CVX","EffectiveDate":"2014-07-17","Type":"RatingNeutral","Title":"Deutsche Bank maintains CVX to Buy. Target Price is $157; previously $142.","DailyReturn":"-0.61%","FiveDayReturnAfter":"2.25%","FiveDayReturnBefore":"-0.38%"},{"Ticker":"CVX","EffectiveDate":"2014-07-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.86%","FiveDayReturnAfter":"-0.38%","FiveDayReturnBefore":"0.64%"},{"Ticker":"CVX","EffectiveDate":"2014-06-10","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on CVX to Buy. Target Price is $142.","DailyReturn":"0.77%","FiveDayReturnAfter":"3.29%","FiveDayReturnBefore":"1.75%"},{"Ticker":"CVX","EffectiveDate":"2014-05-28","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.26%","FiveDayReturnAfter":"-0.23%","FiveDayReturnBefore":"-0.08%"},{"Ticker":"CVX","EffectiveDate":"2014-05-15","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":"-1.22%","FiveDayReturnAfter":"-0.95%","FiveDayReturnBefore":"0.15%"},{"Ticker":"CVX","EffectiveDate":"2014-05-08","Type":"RatingNeutral","Title":"Argus Research downgrades CVX to Hold from Buy. Target Price is $130.","DailyReturn":"-0.9%","FiveDayReturnAfter":"0.15%","FiveDayReturnBefore":"0.56%"},{"Ticker":"CVX","EffectiveDate":"2014-05-02","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.17%","FiveDayReturnAfter":"0.11%","FiveDayReturnBefore":"0.51%"},{"Ticker":"CVX","EffectiveDate":"2014-04-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.1%","FiveDayReturnAfter":"2.1%","FiveDayReturnBefore":"-1.01%"},{"Ticker":"CVX","EffectiveDate":"2014-04-08","Type":"RatingNeutral","Title":"Jefferies initiates coverage on CVX to Buy. Target Price is $140.","DailyReturn":"0.39%","FiveDayReturnAfter":"1.15%","FiveDayReturnBefore":"-1.32%"},{"Ticker":"CVX","EffectiveDate":"2014-04-03","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on CVX to Market Perform. Target Price is $125.","DailyReturn":"-0.25%","FiveDayReturnAfter":"-0.2%","FiveDayReturnBefore":"1.38%"},{"Ticker":"CVX","EffectiveDate":"2014-03-26","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.52%","FiveDayReturnAfter":"1.61%","FiveDayReturnBefore":"0.72%"},{"Ticker":"CVX","EffectiveDate":"2014-02-12","Type":"Dividend","Title":"The Firm pays dividend $1","DailyReturn":"-0.48%","FiveDayReturnAfter":"0.9%","FiveDayReturnBefore":"2.45%"},{"Ticker":"CVX","EffectiveDate":"2014-01-31","Type":"RatingNeutral","Title":"S&P Capital IQ downgrades CVX to Buy from Strong Buy.","DailyReturn":"-4.13%","FiveDayReturnAfter":"-4.55%","FiveDayReturnBefore":"-1.65%"},{"Ticker":"CVX","EffectiveDate":"2014-01-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-4.13%","FiveDayReturnAfter":"-4.55%","FiveDayReturnBefore":"-1.65%"},{"Ticker":"CVX","EffectiveDate":"2014-01-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.71%","FiveDayReturnAfter":"-5.28%","FiveDayReturnBefore":"-2.96%"},{"Ticker":"CVX","EffectiveDate":"2014-01-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.71%","FiveDayReturnAfter":"-5.28%","FiveDayReturnBefore":"-2.96%"},{"Ticker":"CVX","EffectiveDate":"2014-01-29","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-0.71%","FiveDayReturnAfter":"-5.28%","FiveDayReturnBefore":"-2.96%"},{"Ticker":"CVX","EffectiveDate":"2014-01-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0%","FiveDayReturnAfter":"-3.39%","FiveDayReturnBefore":"-1.3%"},{"Ticker":"CVX","EffectiveDate":"2014-01-08","Type":"RatingNeutral","Title":"Scotia Howard Weil downgrades CVX to Sector Perform from Sector Outperform.","DailyReturn":"-1.42%","FiveDayReturnAfter":"-4.49%","FiveDayReturnBefore":"0.67%"},{"Ticker":"CVX","EffectiveDate":"2013-12-12","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on CVX to Sector Perform. Target Price is $120.","DailyReturn":"-0.9%","FiveDayReturnAfter":"-0.41%","FiveDayReturnBefore":"0.27%"},{"Ticker":"CVX","EffectiveDate":"2013-12-11","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-1.26%","FiveDayReturnAfter":"-4.06%","FiveDayReturnBefore":"0.92%"},{"Ticker":"CVX","EffectiveDate":"2013-12-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.26%","FiveDayReturnAfter":"-4.06%","FiveDayReturnBefore":"0.92%"},{"Ticker":"CVX","EffectiveDate":"2013-12-11","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.26%","FiveDayReturnAfter":"-4.06%","FiveDayReturnBefore":"0.92%"},{"Ticker":"CVX","EffectiveDate":"2013-12-06","Type":"RatingNeutral","Title":"HSBC initiates coverage on CVX to Overweight. Target Price is $138.","DailyReturn":"0.98%","FiveDayReturnAfter":"-0.09%","FiveDayReturnBefore":"-1.08%"},{"Ticker":"CVX","EffectiveDate":"2013-11-14","Type":"Dividend","Title":"The Firm pays dividend $1","DailyReturn":"0.39%","FiveDayReturnAfter":"2.41%","FiveDayReturnBefore":"-0.87%"},{"Ticker":"CVX","EffectiveDate":"2013-11-04","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Outperform. Target Price is $140; previously $135.","DailyReturn":"0.07%","FiveDayReturnAfter":"2.65%","FiveDayReturnBefore":"-2.16%"},{"Ticker":"CVX","EffectiveDate":"2013-11-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.62%","FiveDayReturnAfter":"-0.04%","FiveDayReturnBefore":"-0.49%"},{"Ticker":"CVX","EffectiveDate":"2013-10-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.51%","FiveDayReturnAfter":"1.2%","FiveDayReturnBefore":"-3.85%"},{"Ticker":"CVX","EffectiveDate":"2013-08-15","Type":"Dividend","Title":"The Firm pays dividend $1","DailyReturn":"-0.66%","FiveDayReturnAfter":"-2.8%","FiveDayReturnBefore":"-1.04%"},{"Ticker":"CVX","EffectiveDate":"2013-08-02","Type":"EarningsRevenueMiss","Title":"Before market open, CVX reports 2013 Q2's earning $2.77 per share and revenue $55307MM. This misses analyst's estimated EPS $2.98, misses estimated revenue $56010MM.","DailyReturn":"-1.17%","FiveDayReturnAfter":"-2.7%","FiveDayReturnBefore":"-1.03%"},{"Ticker":"CVX","EffectiveDate":"2013-08-02","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.17%","FiveDayReturnAfter":"-2.7%","FiveDayReturnBefore":"-1.03%"},{"Ticker":"CVX","EffectiveDate":"2013-07-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.3%","FiveDayReturnAfter":"0.68%","FiveDayReturnBefore":"3.45%"},{"Ticker":"CVX","EffectiveDate":"2013-06-24","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.77%","FiveDayReturnAfter":"-0.49%","FiveDayReturnBefore":"-1.12%"},{"Ticker":"CVX","EffectiveDate":"2013-06-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.77%","FiveDayReturnAfter":"-0.49%","FiveDayReturnBefore":"-1.12%"},{"Ticker":"CVX","EffectiveDate":"2013-06-20","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on CVX to Outperform.","DailyReturn":"-2.11%","FiveDayReturnAfter":"-1.96%","FiveDayReturnBefore":"0.44%"},{"Ticker":"CVX","EffectiveDate":"2013-06-17","Type":"RatingNeutral","Title":"Jefferies downgrades CVX to Hold from Buy.","DailyReturn":"0.78%","FiveDayReturnAfter":"-1.12%","FiveDayReturnBefore":"-1.17%"},{"Ticker":"CVX","EffectiveDate":"2013-06-05","Type":"RatingNeutral","Title":"Barclays downgrades CVX to Equal-Weight from Overweight. Target Price is $145; previously $133.","DailyReturn":"-1.13%","FiveDayReturnAfter":"-1.23%","FiveDayReturnBefore":"-2.78%"},{"Ticker":"CVX","EffectiveDate":"2013-05-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.74%","FiveDayReturnAfter":"-2.78%","FiveDayReturnBefore":"1.31%"},{"Ticker":"CVX","EffectiveDate":"2013-05-29","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.74%","FiveDayReturnAfter":"-2.78%","FiveDayReturnBefore":"1.31%"},{"Ticker":"CVX","EffectiveDate":"2013-05-15","Type":"Dividend","Title":"The Firm pays dividend $1","DailyReturn":"-0.79%","FiveDayReturnAfter":"1.55%","FiveDayReturnBefore":"1.58%"},{"Ticker":"CVX","EffectiveDate":"2013-04-26","Type":"EarningBeat","Title":"Before market open, CVX reports 2013 Q1's earning $3.18 per share and revenue $54296MM. This beats analyst's estimated EPS $3.06.","DailyReturn":"1.29%","FiveDayReturnAfter":"2.93%","FiveDayReturnBefore":"2.49%"},{"Ticker":"CVX","EffectiveDate":"2013-04-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.29%","FiveDayReturnAfter":"2.93%","FiveDayReturnBefore":"2.49%"},{"Ticker":"CVX","EffectiveDate":"2013-04-18","Type":"RatingNeutral","Title":"Jefferies maintains CVX to Buy. Target Price is $135; previously $125.","DailyReturn":"0.67%","FiveDayReturnAfter":"2.97%","FiveDayReturnBefore":"-4.12%"},{"Ticker":"CVX","EffectiveDate":"2013-04-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.84%","FiveDayReturnAfter":"-1.38%","FiveDayReturnBefore":"-0.3%"},{"Ticker":"CVX","EffectiveDate":"2013-04-10","Type":"RatingNeutral","Title":"Morgan Stanley maintains CVX to Overweight. Target Price is $135; previously $130.","DailyReturn":"0.84%","FiveDayReturnAfter":"-1.38%","FiveDayReturnBefore":"-0.3%"},{"Ticker":"CVX","EffectiveDate":"2013-03-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.65%","FiveDayReturnAfter":"-2.68%","FiveDayReturnBefore":"1.26%"},{"Ticker":"CVX","EffectiveDate":"2013-03-27","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.65%","FiveDayReturnAfter":"-2.68%","FiveDayReturnBefore":"1.26%"},{"Ticker":"CVX","EffectiveDate":"2013-03-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.65%","FiveDayReturnAfter":"-2.68%","FiveDayReturnBefore":"1.26%"},{"Ticker":"CVX","EffectiveDate":"2013-03-27","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-0.65%","FiveDayReturnAfter":"-2.68%","FiveDayReturnBefore":"1.26%"},{"Ticker":"CVX","EffectiveDate":"2013-03-13","Type":"RatingNeutral","Title":"Bank of America maintains CVX to Neutral. Target Price is $130; previously $125.","DailyReturn":"0.09%","FiveDayReturnAfter":"1.01%","FiveDayReturnBefore":"0.27%"},{"Ticker":"CVX","EffectiveDate":"2013-03-13","Type":"RatingNeutral","Title":"Cowen & Co. maintains CVX to Buy. Target Price is $133; previously $129.","DailyReturn":"0.09%","FiveDayReturnAfter":"1.01%","FiveDayReturnBefore":"0.27%"},{"Ticker":"CVX","EffectiveDate":"2013-02-26","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.25%","FiveDayReturnAfter":"3.41%","FiveDayReturnBefore":"-1.24%"},{"Ticker":"CVX","EffectiveDate":"2013-02-22","Type":"RatingNeutral","Title":"Canaccord Genuity initiates coverage on CVX to Buy. Target Price is $136.","DailyReturn":"0.84%","FiveDayReturnAfter":"1.86%","FiveDayReturnBefore":"-0.46%"},{"Ticker":"CVX","EffectiveDate":"2013-02-13","Type":"Dividend","Title":"The Firm pays dividend $0.9","DailyReturn":"-0.06%","FiveDayReturnAfter":"-0.52%","FiveDayReturnBefore":"0.59%"},{"Ticker":"CVX","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"UBS downgrades CVX to Neutral from Buy.","DailyReturn":"-1.11%","FiveDayReturnAfter":"-0.74%","FiveDayReturnBefore":"0.25%"},{"Ticker":"CVX","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Dahlman Rose maintains CVX to Buy. Target Price is $129; previously $120.","DailyReturn":"-1.11%","FiveDayReturnAfter":"-0.74%","FiveDayReturnBefore":"0.25%"},{"Ticker":"CVX","EffectiveDate":"2013-02-01","Type":"RatingNeutral","Title":"Oracle Investment Research downgrades CVX to Hold from Buy. Target Price is $110.","DailyReturn":"1.17%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"-0.3%"},{"Ticker":"CVX","EffectiveDate":"2013-02-01","Type":"RatingNeutral","Title":"Societe Generale downgrades CVX to Hold from Buy. Target Price is $126.","DailyReturn":"1.17%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"-0.3%"},{"Ticker":"CVX","EffectiveDate":"2013-02-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.17%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"-0.3%"},{"Ticker":"CVX","EffectiveDate":"2013-01-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.64%","FiveDayReturnAfter":"-1.2%","FiveDayReturnBefore":"1.11%"},{"Ticker":"CVX","EffectiveDate":"2013-01-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.84%","FiveDayReturnAfter":"3.96%","FiveDayReturnBefore":"-0.77%"},{"Ticker":"CVX","EffectiveDate":"2012-12-06","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Outperform. Target Price is $135; previously $130.","DailyReturn":"1.21%","FiveDayReturnAfter":"2.72%","FiveDayReturnBefore":"-0.38%"},{"Ticker":"CVX","EffectiveDate":"2012-12-06","Type":"RatingUpgrade","Title":"Dahlman Rose upgrades CVX to Buy from Hold. Target Price is $120.","DailyReturn":"1.21%","FiveDayReturnAfter":"2.72%","FiveDayReturnBefore":"-0.38%"},{"Ticker":"CVX","EffectiveDate":"2012-12-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.16%","FiveDayReturnAfter":"3.57%","FiveDayReturnBefore":"0.55%"},{"Ticker":"CVX","EffectiveDate":"2012-12-05","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.16%","FiveDayReturnAfter":"3.57%","FiveDayReturnBefore":"0.55%"},{"Ticker":"CVX","EffectiveDate":"2012-11-14","Type":"Dividend","Title":"The Firm pays dividend $0.9","DailyReturn":"-1.8%","FiveDayReturnAfter":"-0.78%","FiveDayReturnBefore":"-4.71%"},{"Ticker":"CVX","EffectiveDate":"2012-11-05","Type":"RatingNeutral","Title":"UBS maintains CVX to Buy. Target Price is $120; previously $125.","DailyReturn":"0.75%","FiveDayReturnAfter":"-2.36%","FiveDayReturnBefore":"-1.22%"},{"Ticker":"CVX","EffectiveDate":"2012-11-02","Type":"EarningsRevenueMiss","Title":"Before market open, CVX reports 2012 Q3's earning $2.69 per share and revenue $56000MM. This misses analyst's estimated EPS $2.83, misses estimated revenue $64090MM.","DailyReturn":"-2.77%","FiveDayReturnAfter":"-5.14%","FiveDayReturnBefore":"1.88%"},{"Ticker":"CVX","EffectiveDate":"2012-11-02","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.77%","FiveDayReturnAfter":"-5.14%","FiveDayReturnBefore":"1.88%"},{"Ticker":"CVX","EffectiveDate":"2012-10-10","Type":"RatingNeutral","Title":"Societe Generale maintains CVX to Buy. Target Price is $130; previously $131.","DailyReturn":"-4.18%","FiveDayReturnAfter":"-2.82%","FiveDayReturnBefore":"-0.51%"},{"Ticker":"CVX","EffectiveDate":"2012-10-10","Type":"RatingNeutral","Title":"Dahlman Rose initiates coverage on CVX to Hold.","DailyReturn":"-4.18%","FiveDayReturnAfter":"-2.82%","FiveDayReturnBefore":"-0.51%"},{"Ticker":"CVX","EffectiveDate":"2012-10-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.22%","FiveDayReturnAfter":"-4.16%","FiveDayReturnBefore":"0.31%"},{"Ticker":"CVX","EffectiveDate":"2012-10-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.54%","FiveDayReturnAfter":"-0.51%","FiveDayReturnBefore":"0.87%"},{"Ticker":"CVX","EffectiveDate":"2012-10-03","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.54%","FiveDayReturnAfter":"-0.51%","FiveDayReturnBefore":"0.87%"},{"Ticker":"CVX","EffectiveDate":"2012-10-01","Type":"RatingNeutral","Title":"Bank of America maintains CVX to Neutral. Target Price is $125; previously $110.","DailyReturn":"0.59%","FiveDayReturnAfter":"0.8%","FiveDayReturnBefore":"-1.05%"},{"Ticker":"CVX","EffectiveDate":"2012-09-27","Type":"RatingNeutral","Title":"VTB Capital initiates coverage on CVX to Hold. Target Price is $120.","DailyReturn":"0.77%","FiveDayReturnAfter":"-0.13%","FiveDayReturnBefore":"-0.25%"},{"Ticker":"CVX","EffectiveDate":"2012-09-24","Type":"RatingUpgrade","Title":"Scotia Howard Weil upgrades CVX to Market Outperform from Market Perform.","DailyReturn":"-0.01%","FiveDayReturnAfter":"-1.05%","FiveDayReturnBefore":"0.46%"},{"Ticker":"CVX","EffectiveDate":"2012-09-20","Type":"RatingNeutral","Title":"JP Morgan maintains CVX to Neutral. Target Price is $123; previously $120.","DailyReturn":"1.07%","FiveDayReturnAfter":"-0.25%","FiveDayReturnBefore":"1.83%"},{"Ticker":"CVX","EffectiveDate":"2012-09-19","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Outperform. Target Price is $135; previously $120.","DailyReturn":"-0.31%","FiveDayReturnAfter":"-0.03%","FiveDayReturnBefore":"2.41%"},{"Ticker":"CVX","EffectiveDate":"2012-08-15","Type":"Dividend","Title":"The Firm pays dividend $0.9","DailyReturn":"0.13%","FiveDayReturnAfter":"-0.39%","FiveDayReturnBefore":"1.21%"},{"Ticker":"CVX","EffectiveDate":"2012-08-06","Type":"RatingNeutral","Title":"Oppenheimer maintains CVX to Outperform. Target Price is $130; previously $120.","DailyReturn":"0.17%","FiveDayReturnAfter":"2.16%","FiveDayReturnBefore":"1.68%"},{"Ticker":"CVX","EffectiveDate":"2012-07-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.91%","FiveDayReturnAfter":"0.9%","FiveDayReturnBefore":"-0.52%"},{"Ticker":"CVX","EffectiveDate":"2012-07-27","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CVX reports 2012 Q2's earning $3.56 per share and revenue $60000MM. This beats analyst's estimated EPS $3.24, misses estimated revenue $68560MM.","DailyReturn":"0.91%","FiveDayReturnAfter":"0.9%","FiveDayReturnBefore":"-0.52%"},{"Ticker":"CVX","EffectiveDate":"2012-07-12","Type":"RatingUpgrade","Title":"JP Morgan upgrades CVX to Neutral from Underweight. Target Price is $120.","DailyReturn":"0.17%","FiveDayReturnAfter":"2.84%","FiveDayReturnBefore":"-2.37%"},{"Ticker":"CVX","EffectiveDate":"2012-07-11","Type":"RatingNeutral","Title":"Citigroup maintains CVX to Buy. Target Price is $120; previously $126.","DailyReturn":"0.93%","FiveDayReturnAfter":"3.36%","FiveDayReturnBefore":"-1.88%"},{"Ticker":"CVX","EffectiveDate":"2012-07-11","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.93%","FiveDayReturnAfter":"3.36%","FiveDayReturnBefore":"-1.88%"},{"Ticker":"CVX","EffectiveDate":"2012-05-30","Type":"RatingNeutral","Title":"Oppenheimer maintains CVX to Outperform. Target Price is $120; previously $130.","DailyReturn":"-2.6%","FiveDayReturnAfter":"-3.81%","FiveDayReturnBefore":"0.55%"},{"Ticker":"CVX","EffectiveDate":"2012-05-30","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-2.6%","FiveDayReturnAfter":"-3.81%","FiveDayReturnBefore":"0.55%"},{"Ticker":"CVX","EffectiveDate":"2012-05-16","Type":"Dividend","Title":"The Firm pays dividend $0.9","DailyReturn":"0.1%","FiveDayReturnAfter":"-0.68%","FiveDayReturnBefore":"-1.9%"},{"Ticker":"CVX","EffectiveDate":"2012-04-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.01%","FiveDayReturnAfter":"-0.21%","FiveDayReturnBefore":"3.55%"},{"Ticker":"CVX","EffectiveDate":"2012-04-25","Type":"EarningsRelease","Title":"Before market open, CVX reports 2012 Q1's earning $3.27 per share and revenue $58896MM..","DailyReturn":"0.79%","FiveDayReturnAfter":"4.96%","FiveDayReturnBefore":"-0.57%"},{"Ticker":"CVX","EffectiveDate":"2012-04-10","Type":"RatingNeutral","Title":"Citigroup maintains CVX to Buy. Target Price is $126; previously $124.","DailyReturn":"-1.97%","FiveDayReturnAfter":"-1.93%","FiveDayReturnBefore":"-3.53%"},{"Ticker":"CVX","EffectiveDate":"2012-04-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.97%","FiveDayReturnAfter":"-1.93%","FiveDayReturnBefore":"-3.53%"},{"Ticker":"CVX","EffectiveDate":"2012-03-29","Type":"RatingNeutral","Title":"Morgan Stanley maintains CVX to Overweight. Target Price is $126; previously $137.","DailyReturn":"0.9%","FiveDayReturnAfter":"-0.27%","FiveDayReturnBefore":"-1.88%"},{"Ticker":"CVX","EffectiveDate":"2012-03-28","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-1.07%","FiveDayReturnAfter":"0.09%","FiveDayReturnBefore":"-1.88%"},{"Ticker":"CVX","EffectiveDate":"2012-03-28","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.07%","FiveDayReturnAfter":"0.09%","FiveDayReturnBefore":"-1.88%"},{"Ticker":"CVX","EffectiveDate":"2012-03-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.07%","FiveDayReturnAfter":"0.09%","FiveDayReturnBefore":"-1.88%"},{"Ticker":"CVX","EffectiveDate":"2012-03-28","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.07%","FiveDayReturnAfter":"0.09%","FiveDayReturnBefore":"-1.88%"},{"Ticker":"CVX","EffectiveDate":"2012-02-29","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades CVX to Buy from Hold. Target Price is $130; previously $115.","DailyReturn":"-0.44%","FiveDayReturnAfter":"-0.69%","FiveDayReturnBefore":"1.1%"},{"Ticker":"CVX","EffectiveDate":"2012-02-15","Type":"Dividend","Title":"The Firm pays dividend $0.81","DailyReturn":"-0.64%","FiveDayReturnAfter":"1.7%","FiveDayReturnBefore":"-0.31%"}];